Non-compete disputes often follow a similar pattern. And part of that pattern involves the dreaded "cease-and-desist" letter. These letters are precursors to litigation, and they can be either ...

Debt collection harassment is an invasive and stressful experience—especially when it comes from aggressive agencies like ...

PGCB targets 18 unlicensed sweepstakes sites, citing legal loopholes and threats to the regulated gambling industry in ...

Eli Lilly's (LLY) cease-and-desist letter is dismissed by weight loss drug compounder, OrderlyMeds. Read more here.

ATLANTA, April 11, 2025 /PRNewswire/ -- On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response.